MedClub Page @MedClub
127.5K 76 41
Diagnosis and treatment according to the new guidelines. Follow us: https://twitter.com/MedClubPage | https://www.facebook.com/MedClubPag | http://instagram.com/medclubpage
Contributor Ranks
Latest Searches
13 results
diagnosis oncology cardiology types algorithm breast dissection management syphilis acidosis aortic artery burn carpentier chancre checkpoint clinical coronary debakey degrees
Breast Cancer Subtypes Histological Subtypes: • Preinvasive: Ductal carcinoma in situ (DCIS). Lobular carcinoma in situ
Breast Cancer Subtypes ... 0111-2 #Breast #Cancer ... Subtypes #oncology #classification
Hepatitis B Management in Cancer DOI: 10.1200/JCO.20.01757 #HepatitisB #HBV #HepBV #Management #Cancer #oncology #hepatology #algorithm
Management in Cancer ... HepBV #Management #Cancer
Early Breast Cancer - Management Algorithm • Luminal A-like (ER+ and/or PR+, HER2- and low proliferation)
Early Breast Cancer ... Early #Breast #Cancer
Endometrial Cancer Staging - Primary Tumor (T) - Regional Lymph Nodes (N) - Distant Metastasis (M) DOI:
Endometrial Cancer ... #Endometrial #Cancer
Aortic Dissection - Stanford / DeBakey Classification Stanford A / DeBakey II - Dissection involving the ascending
Stanford / DeBakey Classification ... Stanford #DeBakey #Classification
Myocardial Injury Classification Chronic myocardial injury: Chronic heart failure, Cardiomyopathy, Hypertension, CKD/ESRD Acute nonischemic myocardial injury: - Primary
Myocardial Injury Classification ... Myocardial #Injury #Classification
Lactic Acidosis - Classification and Differential Diagnosis Type A Lactic Acidosis: Inadequate Oxygen Delivery • Anaerobic muscular
Lactic Acidosis - Classification ... Lactic #Acidosis #Classification
Burn Injury - Depth and Grading Degrees Superficial thickness (first degree): • Painful, Does not blister,
Grading #Degrees #classification
Natural History of Syphilis Primary - 2-6 weeks after infection • Chancre, Regional lymphadenopathy Early Latent ≤ 1
after infection • Chancre
Checkpoint inhibitors and indications Anti CTLA-4 antibody: • Ipilimumab: Malignant melanoma, Renal cell cancer Anti-PD-1 antibody: • Nivolumab:
, Renal cell cancer ... Head and neck cancer ... , Gastric cancer ... , Solid cancers ... , Breast cancer
empty